Manager, Financial Institutions Consulting

IQVIA•New York, NY

5d•$167,640 - $273,000•Onsite

About The Position

This role involves executing commercial and technical due diligence on global M&A deals, coordinating cross-functional teams, preparing market forecasts, and conducting qualitative and quantitative analysis for private equity and corporate clients. The position requires coordinating project delivery for global financial institutions and biopharma clients, conducting strategic forecasting, reconciling data sources, and providing re-flag analysis. The Manager will serve as a direct client contact, contribute to business development proposals, develop thought leadership materials, facilitate client workshops, and support internal team development through mentorship and training. The role also includes conducting interviews with healthcare professionals and regulatory bodies, integrating knowledge of US and EU pharmaceutical markets, and applying knowledge of healthcare markets and financial institution business models to inform client investment strategy. The position has supervisory responsibilities for associate consultants and consultants.

Requirements

Requires a bachelor’s degree in Pharmaceutical Sciences, Biology, Chemistry, Finance, Epidemiology, Public Health or related field or foreign equivalent.
Requires five (5) years of progressively responsible experience in consulting or transaction advisory roles in mergers and acquisitions.
Requires five (5) years with the following: EU and US Pharma Market Experience.
Requires five (5) years advising clients or financial investors on commercial issues in the biopharma or life sciences industry, including exposure to projects related to transactions or investments (due diligence, valuation, asset identification, growth strategy, forecasting).
Requires five (5) years of project management experience including managing internal and external team members (2+) multi-disciplined teams including Consultants, Value & Access Experts, Therapeutic Area Subject Matter Experts, Data Analysts, or Primary Market Research Vendors.
Requires five (5) years performing project planning, workstream oversight, presentation or report development, quality control and client engagement.
Requires five (5) years performing quantitative and qualitative research.
Requires five (5) years interpreting commercial and financial trends and results to translate outputs into strategic implications for investors.

Responsibilities

Execute commercial and technical due diligence on 2 – 3 projects per month on global M&A deals ranging from $500-$2Bn by coordinating cross-functional teams of 2–7+ consultants across U.S., EU, and India offices.
Prepare team-building market forecasts, qualitative and quantitative analysis for buy- and sell-side due diligence for PE and corporate M&A transactions and communicate complex issues and investment considerations to clients.
Coordinate project delivery for global financial institutions (including private equity, venture capital, hedge funds) and biopharma clients, including regulatory, clinical, and commercial assessments to support assets, portfolio, and company valuations.
Conduct strategic forecasting using methodologies such as probability of technical and regulatory success (PTRS) and risk-adjusted Net Present Value (rNPV) to evaluate investment opportunities across diverse geographies (U.S., EU, MENA, ROW).
Reconcile data sources across prescriptions and claims across IQVIA and external data sets.
Provide re-flag analysis based on target’s commercial materials in the areas of promotion spend, organizational structure and contracting (eg., wholesalers / payers etc.) and make recommendations for further deep-dive analysis.
Serve as direct point of contact for clients, including private equity, venture capital, and hedge funds, providing strategic guidance and presenting key insights.
Contribute to 1–2 business development proposals per month with total contract values up to $500K.
Develop quarterly thought leadership materials on biopharma investment trends and strategic frameworks.
Facilitate client workshops for franchise strategy development and M&A target screening.
Support internal team development through monthly meetings, quarterly global alignment sessions, and mentorship of junior consultants.
Conduct team interviews with healthcare professionals, payers & regulatory bodies to assess unmet needs, target product profile, competitive landscape, and pricing potential.
Integrate knowledge of US and EU pharmaceutical markets, to provide clients with necessary diligence pertaining to global operations, including Health Technology Assessment (HTA) analysis, understanding pricing and market access systems by country, HTA assessment outcomes and drug pricing implications.
Apply knowledge of healthcare markets, services (e.g., contract, development and manufacturing organizations (CDMO), contract research organizations (CRO), ambulatory services and infusion clinics, site management organizations (SMOs), and financial institution business models to inform client investment strategy.
Serve as direct point of contact for clients, including private equity, venture capital, and hedge funds, providing strategic guidance and presenting key insights.
Requires supervisory responsibilities to associate consultants, consultants, or related position (varies depending on project).